BRPI0609946A2 - derivados de imidazo [1,2-a] piridina úteis como inibidores de peptìdio deformilase (pdf) - Google Patents

derivados de imidazo [1,2-a] piridina úteis como inibidores de peptìdio deformilase (pdf) Download PDF

Info

Publication number
BRPI0609946A2
BRPI0609946A2 BRPI0609946-7A BRPI0609946A BRPI0609946A2 BR PI0609946 A2 BRPI0609946 A2 BR PI0609946A2 BR PI0609946 A BRPI0609946 A BR PI0609946A BR PI0609946 A2 BRPI0609946 A2 BR PI0609946A2
Authority
BR
Brazil
Prior art keywords
group
formula
atom
groups
compounds according
Prior art date
Application number
BRPI0609946-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Michael Thormann
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0609946A2 publication Critical patent/BRPI0609946A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BRPI0609946-7A 2005-04-25 2006-04-24 derivados de imidazo [1,2-a] piridina úteis como inibidores de peptìdio deformilase (pdf) BRPI0609946A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005019181A DE102005019181A1 (de) 2005-04-25 2005-04-25 Peptid-Deformylase (PDF) Inhibitoren 1
DE102005019181.9 2005-04-25
PCT/EP2006/003767 WO2006114263A1 (en) 2005-04-25 2006-04-24 Imidazo [1, 2-a] pyridine derivatives useful as peptide deformylase (pdf) inhibitors

Publications (1)

Publication Number Publication Date
BRPI0609946A2 true BRPI0609946A2 (pt) 2010-05-11

Family

ID=36692610

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0609946-7A BRPI0609946A2 (pt) 2005-04-25 2006-04-24 derivados de imidazo [1,2-a] piridina úteis como inibidores de peptìdio deformilase (pdf)

Country Status (12)

Country Link
US (2) US7662833B2 (enExample)
EP (1) EP1877408A1 (enExample)
JP (1) JP2008538778A (enExample)
KR (1) KR20080002867A (enExample)
CN (1) CN101163703B (enExample)
AU (1) AU2006239548B8 (enExample)
BR (1) BRPI0609946A2 (enExample)
CA (1) CA2605925A1 (enExample)
DE (1) DE102005019181A1 (enExample)
MX (1) MX2007013225A (enExample)
RU (1) RU2420526C2 (enExample)
WO (1) WO2006114263A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008068392A1 (fr) * 2006-12-07 2008-06-12 Commissariat A L'energie Atomique Nouveaux derives fluorophores imidazo [1,2-a] pyridin-3-yl-amine et leur procede de preparation
WO2008141239A1 (en) * 2007-05-10 2008-11-20 Acadia Pharmaceuticals Inc. Imidazol [1,2-a] pyridines and related compounds with activity at cannabinoid cb2 receptors
DE102007040336A1 (de) 2007-08-27 2009-03-05 Johann Wolfgang Goethe-Universität Frankfurt am Main Neue Inhibitoren der 5-Lipoxygenase und deren Verwendungen
FR2925903B1 (fr) * 2008-01-02 2011-01-21 Sanofi Aventis DERIVES 6-HETEROCYCLIQUE-IMIDAZO°1,2-a!PYRIDINE-2- CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
WO2010032195A1 (en) * 2008-09-16 2010-03-25 Csir Imidazopyridines and imidazopyrimidines as hiv-i reverse transcriptase inhibitors
CN101729939B (zh) * 2008-10-31 2012-12-05 中兴通讯股份有限公司 无源光网络带宽分配方法及系统
WO2011041713A2 (en) * 2009-10-02 2011-04-07 Glaxosmithkline Llc Piperazinyl antiviral agents
EP2601194B1 (en) * 2010-08-03 2016-05-25 Merck Sharp & Dohme Corp. Fused-imidazoyl compounds useful as antimicrobial agents
WO2012087833A1 (en) 2010-12-22 2012-06-28 Abbott Laboratories Hepatitis c inhibitors and uses thereof
SG11201400988SA (en) * 2011-10-21 2014-07-30 Glaxosmithkline Llc Compounds and methods for enhancing innate immune responses
KR101650539B1 (ko) 2014-10-15 2016-08-26 장준구 다각도로 발광하는 led패키지
CN107245050B (zh) * 2016-12-05 2019-10-25 徐州医科大学 香草醛异羟肟酸类衍生物及其应用
EP3750878B1 (en) 2019-06-14 2025-05-14 Vivoryon Therapeutics N.V. Heteroaromatic inhibitors of astacin proteinases

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU176214B (en) * 1977-05-18 1981-01-28 Chinoin Gyogyszer Es Vegyeszet Process for producing new 5,6-dihydro-imidazo-square bracket-5,1-a-square bracket closed-isoquinolin derivatives
CA1164459A (en) * 1980-11-11 1984-03-27 Yung-Hsiung Yang Process for preparing (imidazo¬1,2-a|pyridine- 2-yl)-carbostyril or -3,4-dihydrocarbostyryl derivatives
JPS61218589A (ja) * 1985-03-26 1986-09-29 Eisai Co Ltd ５―（６―イミダゾ〔１，２―ａ〕ピリジニル）ピリジン誘導体
JPH0717971A (ja) * 1993-07-02 1995-01-20 Takeda Chem Ind Ltd イミダゾール誘導体、その製造法及び用途
CZ297278B6 (cs) * 1996-08-07 2006-10-11 Darwin Discovery Limited Deriváty hydroxamové a karboxylové kyseliny a jejich pouzití
AR029916A1 (es) * 2000-05-05 2003-07-23 Smithkline Beecham Corp N-formil-n-hidroxi-ariloxi alquilaminas y metodos para tratar infecciones bacterianas
DE10050663A1 (de) * 2000-10-13 2002-04-18 Gruenenthal Gmbh Verwendung von substituierten Imidazo[1,2-a]pyridin-, -pyrimidin- und pyrazin-3-yl-amin-Derivaten zur Herstellung von Medikamenten zur NOS-Inhibierung
TWI312347B (en) * 2001-02-08 2009-07-21 Eisai R&D Man Co Ltd Bicyclic nitrogen-containing condensed ring compounds
DE10150172A1 (de) * 2001-10-11 2003-04-30 Morphochem Ag Neue Verbindungen, die Protein Tyrosin Phosphatase 1B (PTP-1B) inhibieren
US20040127719A1 (en) * 2002-03-08 2004-07-01 Kexin Yang Alpha-isocyanocarboxylate solid support templates, method of preparation and for using the same
UY27813A1 (es) 2002-05-31 2003-12-31 Smithkline Beecham Corp Inhibidores de la peptido-desformilasa
US7442793B2 (en) * 2002-12-11 2008-10-28 Smithkline Beecham Corporation Peptide deformylase inhibitors

Also Published As

Publication number Publication date
EP1877408A1 (en) 2008-01-16
AU2006239548B2 (en) 2010-04-29
MX2007013225A (es) 2007-12-12
JP2008538778A (ja) 2008-11-06
AU2006239548B8 (en) 2010-08-26
CN101163703A (zh) 2008-04-16
KR20080002867A (ko) 2008-01-04
CN101163703B (zh) 2010-12-15
CA2605925A1 (en) 2006-11-02
WO2006114263A1 (en) 2006-11-02
US20090215816A1 (en) 2009-08-27
DE102005019181A1 (de) 2006-10-26
RU2420526C2 (ru) 2011-06-10
RU2007143512A (ru) 2009-06-10
US20080188515A1 (en) 2008-08-07
US7662833B2 (en) 2010-02-16
AU2006239548A1 (en) 2006-11-02

Similar Documents

Publication Publication Date Title
Natchus et al. Design and synthesis of conformationally-constrained MMP inhibitors
EP1877408A1 (en) Imidazo [1, 2-a]pyridine derivatives useful as peptide deformylase (pdf) inhibitors
US20050228017A1 (en) Novel anticancer compounds
BRPI0708487A2 (pt) composto, composição farmacêutica que o compreende e seu uso
RU2379284C2 (ru) Новые биоизостеры актинонина
BRPI0610842A2 (pt) derivados de imidazo(1,2-a) piridina úteis como inibidores de peptìdeo desformilase (pdf)
CA3216280A1 (en) Class iia histone deacetylase (hdac) degrader ligands and methods of use thereof
BRPI0611694A2 (pt) inibidores peptìdicos da deformilase 4 (pdf)
US20250170104A1 (en) INHIBITORS OF PSEUDOMONAS AERUGINOSA VIRULENCE FACTOR Lasß
WO2011050994A2 (en) Closthioamides
CA2491422A1 (en) Novel macrocycles for the treatment of cancer diseases
CA3232883A1 (en) Small molecule inhibitors of bacterial toxins
EP4126833A1 (en) N-phenyl-3-mercaptopropanamide derivatives as metallo-beta-lactamase inhibitors for the treatment of bacterial infections
AU2002351814A1 (en) Novel anticancer compounds

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUI DADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2212 DE 28/05/2013.